(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Sepsis Diagnostics market is accounted for $330.74 million in 2015 and is expected to reach $659.36 million by 2022 growing at a CAGR of 10.4%. This life-threatening condition of Sepsis arises when the body's response to infection...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Defibrillators market is accounted for $10.61 billion in 2015 and is expected to reach $19.31 billion by 2022 growing at a CAGR of 8.9%. The defibrillation is a procedure comprising of delivering an electric shock to the heart,...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Clinical Alarm Management Market is accounted for $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% during the forecast period. Increased investments by governments across the world and...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Sterile Filtration Market is accounted for $4.12 billion in 2015 and is expected to reach $9.57 billion by 2022 growing at a CAGR of 12.7% during the forecast period. Factors such as increasing prevalence of diabetes & kidney...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Surgical Power Tools Market is expected to grow at a CAGR of 4.5% during the forecast period. Technological advancements, rising surgical procedures and growing usage of battery-driven cordless surgical power tools are fueling...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Micromanipulators Market is accounted for $49.25 million in 2015 and is expected to reach $211.26 million by 2022 growing at a CAGR of 23.12% during the forecast period. Increase in disposable income, rising male infertility,...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Clinical Microbiology Market is accounted for $3.05 billion in 2015 and is expected to reach $6.72 billion by 2022 growing at a CAGR of 11.9% during the forecast period. Growing prevalence of infectious diseases, technological...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Allergy Diagnostics Market is accounted for $2.70 billion in 2015 and is expected to reach $6.29 billion by 2022 growing at a CAGR of 12.8% during the forecast period. Factors such as rising healthcare expenses, growing environmental...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Refractometers market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Rising developments in technology is favouring the refractometers market to...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing pervasiveness of type 1 diabetes and ongoing approvals by the...
(PharmaNewsWire.Com, March 02, 2017 ) According to Publisher, the Global Critical Care Diagnostics market is accounted for $0.8 billion in 2015 and is expected to reach $1.1 billion by 2022 growing at a CAGR of 5.4% from 2015 to 2022. Growing aging population and chronic health concerns, improving...
(PharmaNewsWire.Com, March 02, 2017 ) Publisher's clinical trial report, "Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperphenylalaninemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperphenylalaninemia....
(PharmaNewsWire.Com, March 02, 2017 ) Publisher's clinical trial report, "Hyperammonemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperammonemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperammonemia. Report includes...
(PharmaNewsWire.Com, March 02, 2017 ) Publisher's clinical trial report, "Melasma (Chlosma) Global Clinical Trials Review, H1, 2016" provides an overview of Melasma (Chlosma) clinical trials scenario. This report provides top line data relating to the clinical trials on Melasma (Chlosma). Report...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
